GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » CurveBeam AI Ltd (ASX:CVB) » Definitions » Debt-to-Asset

CurveBeam AI (ASX:CVB) Debt-to-Asset : 0.21 (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is CurveBeam AI Debt-to-Asset?

CurveBeam AI's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$1.02 Mil. CurveBeam AI's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$13.51 Mil. CurveBeam AI's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was A$70.77 Mil. CurveBeam AI's debt to asset for the quarter that ended in Dec. 2023 was 0.21.


CurveBeam AI Debt-to-Asset Historical Data

The historical data trend for CurveBeam AI's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CurveBeam AI Debt-to-Asset Chart

CurveBeam AI Annual Data
Trend Jun21 Jun22 Jun23
Debt-to-Asset
- - 0.24

CurveBeam AI Semi-Annual Data
Jun21 Dec21 Jun22 Jun23 Dec23
Debt-to-Asset - - - 0.24 0.21

Competitive Comparison of CurveBeam AI's Debt-to-Asset

For the Medical Devices subindustry, CurveBeam AI's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CurveBeam AI's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CurveBeam AI's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where CurveBeam AI's Debt-to-Asset falls into.



CurveBeam AI Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

CurveBeam AI's Debt-to-Asset for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1.354 + 13.491) / 61.363
=0.24

CurveBeam AI's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset=Total Debt / Total Assets
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Assets
=(1.016 + 13.511) / 70.769
=0.21

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CurveBeam AI  (ASX:CVB) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


CurveBeam AI Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of CurveBeam AI's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


CurveBeam AI (ASX:CVB) Business Description

Traded in Other Exchanges
N/A
Address
10?16 Queen Street, Level 10, Melbourne, VIC, AUS, 3000
CurveBeam AI Ltd is a manufacturer of specialized imaging equipment that has developed software that, through the use of artificial intelligence (AI), and deep learning AI (DLAI), automates the scan processing and analysis of the high-quality images produced from the Company's CT devices to assist in the clinical assessment and management of musculoskeletal health conditions, with a focus on orthopedic and bone health issues. The Company is the first to market with natural bilateral weight-bearing and non-weight-bearing CT, point-of-care imaging equipment with targeted proprietary AI solutions.

CurveBeam AI (ASX:CVB) Headlines

No Headlines